PHL 00801

Drug Profile

PHL 00801

Alternative Names: Prostatonin; PY 102/UR 102; Pygeum africanum/Urtica dioica extract - Pharmaton

Latest Information Update: 30 Aug 2006

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pharmaton
  • Developer Ginsana
  • Class Phytotherapies
  • Mechanism of Action Aromatase inhibitors; Cholestenone 5-alpha reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Benign prostatic hyperplasia

Most Recent Events

  • 25 Aug 2006 Pharmaton has been acquired by IdeaSphere
  • 21 Mar 2000 A study has been added to the therapeutic trials and adverse events sections
  • 12 Oct 1999 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top